Yesterday, Aug. 1, 2016, 63 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $3,437.91 to $17,001,880.00.

Highlighted Stocks Traded by Insiders:

Supreme Industries (STS) - FREE Research Report

Long Matthew W, who is CFO, Treasurer at Supreme Industries, sold 10,000 shares at $16.61 on Aug. 1, 2016. Following this transaction, the CFO, Treasurer owned 83,667 shares meaning that the stake was reduced by 10.68% with the 10,000-share transaction.

Weber Mark, who is President and CEO at Supreme Industries, sold 20,000 shares at $16.58 on Aug. 1, 2016. Following this transaction, the President and CEO owned 146,310 shares meaning that the stake was reduced by 12.03% with the 20,000-share transaction.

Hogan Thomas B. Jr., who is Director at Supreme Industries, sold 10,000 shares at $16.49 on Aug. 1, 2016. Following this transaction, the Director owned 22,453 shares meaning that the stake was reduced by 30.81% with the 10,000-share transaction.

Gajarsa Arthur J, who is Director at Supreme Industries, sold 5,000 shares at $16.37 on Aug. 1, 2016. Following this transaction, the Director owned 34,283 shares meaning that the stake was reduced by 12.73% with the 5,000-share transaction.

Barrett Peter D, who is Director at Supreme Industries, sold 1,000 shares at $16.56 on Aug. 1, 2016. Following this transaction, the Director owned 16,575 shares meaning that the stake was reduced by 5.69% with the 1,000-share transaction.

The shares most recently traded at $16.33, down $0.23, or 1.41% since the insider transaction. Historical insider transactions for Supreme Industries go as follows:

  • 4-Week # shares bought: 1,779
  • 4-Week # shares sold: 60,954
  • 12-Week # shares bought: 1,779
  • 12-Week # shares sold: 200,481
  • 24-Week # shares bought: 1,779
  • 24-Week # shares sold: 202,434

The average volume for Supreme Industries has been 235,500 shares per day over the past 30 days. Supreme Industries has a market cap of $279.7 million and is part of the consumer goods sector and automotive industry. Shares are up 145.26% year-to-date as of the close of trading on Friday.

Supreme Industries, Inc., through its subsidiary, Supreme Corporation, manufactures and sells truck bodies, trolleys, and specialty vehicles in the United States. It operates through two segments, Specialized Commercial Vehicles and Fiberglass Products. The stock currently has a dividend yield of 0.85%. The company has a P/E ratio of 15.1. Currently, there are no analysts who rate Supreme Industries a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on STS - FREE

TheStreet Quant Ratings

rates Supreme Industries as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, attractive valuation levels, solid stock price performance and impressive record of earnings per share growth. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

Supreme Industries Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Herbalife (HLF) - FREE Research Report

Lamberti Frank, who is SVP, Managing Dir. -North Asia at Herbalife, sold 1,237 shares at $66.10 on Aug. 1, 2016. Following this transaction, the SVP, Managing Dir. -North Asia owned 9,282 shares meaning that the stake was reduced by 11.76% with the 1,237-share transaction.

The shares most recently traded at $67.98, up $1.88, or 2.77% since the insider transaction. Historical insider transactions for Herbalife go as follows:

  • 4-Week # shares bought: 600
  • 4-Week # shares sold: 2,000
  • 12-Week # shares bought: 600

TST Recommends

  • 12-Week # shares sold: 2,000
  • 24-Week # shares bought: 600
  • 24-Week # shares sold: 11,753

The average volume for Herbalife has been 2.1 million shares per day over the past 30 days. Herbalife has a market cap of $6.2 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 26.84% year-to-date as of the close of trading on Friday.

Herbalife Ltd., a nutrition company, develops and sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, and personal care products. The company has a P/E ratio of 19.8. Currently, there are no analysts who rate Herbalife a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HLF - FREE

TheStreet Quant Ratings

rates Herbalife as a

buy

. The company's strengths can be seen in multiple areas, such as its notable return on equity, revenue growth, solid stock price performance, impressive record of earnings per share growth and increase in net income. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full

Herbalife Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Edwards Lifesciences (EW) - FREE Research Report

Sellers Robert W.A., who is VP, Corporate Controller at Edwards Lifesciences, sold 10,000 shares at $114.33 on Aug. 1, 2016. Following this transaction, the VP, Corporate Controller owned 16,782 shares meaning that the stake was reduced by 37.34% with the 10,000-share transaction.

The shares most recently traded at $114.23, down $0.10, or 0.09% since the insider transaction. Historical insider transactions for Edwards Lifesciences go as follows:

  • 4-Week # shares sold: 4,000
  • 12-Week # shares sold: 4,000
  • 24-Week # shares sold: 4,000

The average volume for Edwards Lifesciences has been 1.7 million shares per day over the past 30 days. Edwards Lifesciences has a market cap of $23.9 billion and is part of the health care sector and health services industry. Shares are up 45% year-to-date as of the close of trading on Friday.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company has a P/E ratio of 46.7. Currently, there are 13 analysts who rate Edwards Lifesciences a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EW - FREE

TheStreet Quant Ratings

rates Edwards Lifesciences as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and growth in earnings per share. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full

Edwards Lifesciences Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.